Virtual Library

Start Your Search

  • TTLC 2021

    Targeted Therapies in Lung Cancer 2021

    Access to all slides from presentations that occur during the IASLC 2021 Targeted Therapies of Lung Cancer Meeting

    Presentation Date(s):  
    • February 17 - 20, 2021
    • Total Presentations: 76

Filter Results:

Show Only Available Presentations

  • +

    P01 - Antibody Drug Conjugates

    • Type: Poster
    • Track:
    • Presentations: 1
    • Coordinates: 2/17/2021, 00:00 - 00:00,
    • +

      Female Lung Cancer: An Emerging Issue in Bangladesh

      00:00 - 00:00  |  Author(s): Muhammad Islam

      • Abstract
      • Slides

      Abstract not provided

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    P02 - Immunotherapy - Biomarkers

    • Type: Poster
    • Track:
    • Presentations: 1
    • Coordinates: 2/17/2021, 00:00 - 00:00,
    • +

      Increase in Tumour PD-L1 Expression in Non-small Cell Lung Cancer Following Thermal Vapour Ablation is Not Related to Systemic Inflammatory Response

      00:00 - 00:00  |  Author(s): Kanishka Rangamuwa

      • Abstract
      • Slides

      Abstract not provided

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    P03 - Immunotherapy- IO and other Novel Combinations

    • Type: Poster
    • Track:
    • Presentations: 1
    • Coordinates: 2/17/2021, 00:00 - 00:00,
    • +

      Comparison of Tumor Mutational Burden in Paired Primary Versus Lung Cancer Brain Metastasis

      00:00 - 00:00  |  Author(s): Matthew Strickland

      • Abstract
      • Slides

      Abstract not provided

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    P04 - Immunotherapy - Other Immunologic

    • Type: Poster
    • Track:
    • Presentations: 1
    • Presentations Available
    • Coordinates: 2/17/2021, 00:00 - 00:00,
    • +

      Non-Small Cell Lung Cancer (NSCLC) Comprehensive Genomic Profiling: Integrating Expanded Genomic Sequencing Into the Canadian Publicly Funded Health Care Model (Presentation Available)

      00:00 - 00:00  |  Author(s): Kirstin Perdrizet

      • Abstract
      • Presentation
      • Slides

      Abstract not provided

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    P05 - Small Cell Lung Cancer

    • Type: Poster
    • Track:
    • Presentations: 1
    • Presentations Available
    • Coordinates: 2/17/2021, 00:00 - 00:00,
    • +

      Detection of DNA Replication Blocker SLFN11 in Tumor Tissue and Circulating Tumor Cells to Predict Platinum Response in Small Cell Lung Cancer (Presentation Available)

      00:00 - 00:00  |  Author(s): Bingnan Zhang

      • Abstract
      • Presentation
      • Slides

      Abstract not provided

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    P06 - Stage III/Unresectable

    • Type: Poster
    • Track:
    • Presentations: 1
    • Presentations Available
    • Coordinates: 2/17/2021, 00:00 - 00:00,
    • +

      The ASCENT Trial: A Phase II Study of Neoadjuvant/Adjuvant Afatinib, Chemoradiation +/- Surgery for Stage III EGFR-Mutant NSCLC (Presentation Available)

      00:00 - 00:00  |  Author(s): Andrew Piper-Vallillo

      • Abstract
      • Presentation
      • Slides

      Abstract not provided

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    P07 - Targeted Therapies - ALK & ROS1 Inhibitors

    • Type: Poster
    • Track:
    • Presentations: 2
    • Presentations Available
    • Coordinates: 2/17/2021, 00:00 - 00:00,
    • +

      Management of Advanced Non-small Cell Lung Cancer Patients Harbouring ROS1 Rearrangement- Experience From a Tertiary Cancer Centre in Eastern India (Presentation Available)

      00:00 - 00:00  |  Author(s): Saheli Saha

      • Abstract
      • Presentation
      • Slides

      Abstract not provided

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      Sequencing of TKI With or Without Brain Radiotherapy (RT) in EGFR Mutated or ALK Rearranged Non-small Cell Lung Cancer (NSCLC) with Brain Metastases

      00:00 - 00:00  |  Author(s): Nicholas Giustini

      • Abstract
      • Slides

      Abstract not provided

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    P08 - Targeted Therapies - All The Others

    • Type: Poster
    • Track:
    • Presentations: 1
    • Presentations Available
    • Coordinates: 2/17/2021, 00:00 - 00:00,
    • +

      Precision Targeted Therapy for RET-driven NSCLC and Emerging Evidence of Acquired Resistance to RET-Specific Tyrosine Kinase Inhibitors (Presentation Available)

      00:00 - 00:00  |  Author(s): Johnathan Ebben

      • Abstract
      • Presentation
      • Slides

      Abstract not provided

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    P09 - Targeted Therapies - EGFR

    • Type: Poster
    • Track:
    • Presentations: 5
    • Presentations Available
    • Coordinates: 2/17/2021, 00:00 - 00:00,
    • +

      EGFR-TKIs Associated Cardiotoxicity in Lung Cancer Patients: An Analysis of FAERS Database (Presentation Available)

      00:00 - 00:00  |  Author(s): Dongchen Sun

      • Abstract
      • Presentation
      • Slides

      Abstract not provided

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      Mechanism of Growth-Inhibitory Effect of Pemetrexed Disodium Heptahydrate on Human PC9 (EGFR Exon 19 Deletion) Cells (Presentation Available)

      00:00 - 00:00  |  Author(s): Md Mohiddin

      • Abstract
      • Presentation
      • Slides

      Abstract not provided

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      Mutated EGFR Pulmonary Adenocarcinoma Experience of the Medical Oncology Department of the Hassan II Hospital University in Fez (Presentation Available)

      00:00 - 00:00  |  Author(s): Yassine El Ouai

      • Abstract
      • Presentation
      • Slides

      Abstract not provided

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      Response to Standard Therapies and Comprehensive Genomic Analysis for Patients With Lung Adenocarcinoma With EGFR Exon 20 Insertions (Presentation Available)

      00:00 - 00:00  |  Author(s): Noura Choudhury

      • Abstract
      • Presentation
      • Slides

      Abstract not provided

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      Restoring Therapeutic Efficacy of Osimertinib in EGFR-driven NSCLC by Targeting the BMP/Endoglin Signaling Axis (Presentation Available)

      00:00 - 00:00  |  Author(s): Manish Thiruvalluvan

      • Abstract
      • Presentation
      • Slides

      Abstract not provided

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    P10 - Targeted Therapies - KRAS

    • Type: Poster
    • Track:
    • Presentations: 2
    • Presentations Available
    • Coordinates: 2/17/2021, 00:00 - 00:00,